Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

MicroRNA Analysis Paired with a Novel Live Cell Viability Assay: A Complete Epigenetic Workflow in Human Cancer Cell Lines

Part # PS278


Mark Bratz, Samantha Lewis, Brad Hook, Don Smith and Trista Schagat
Promega Corporation, 2800 Woods Hollow Rd, Madison, WI, 53711

Here we describe tools developed to isolate total RNA, for mRNA and miRNA analyses, in the context of an epigenetic workflow with cancer cell lines. Using this workflow with two breast cancer cell lines, with distinct responses to histone deacetylase(HDAC) inhibition, we can measure cell health, cytotoxicity, HDAC activity, and mRNA plus miRNA expression profiling in a single experiment. The manual total RNA isolation method we describe can also be used with 3D cell cultures.

Printed in USA.